Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Clinical trial NCT07019155 · RECRUITING

Trial details

NCT number: NCT07019155
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Study type: OBSERVATIONAL

Germline Mutation Myelodysplastic Syndromes Acute Myeloid Leukemia

Start date: 2025-07-24
Primary completion: 2035-06-15
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.